The future of T Cell Transfer Therapy looks promising, with continuous advancements being made in genetic engineering and biotechnology. Researchers are exploring ways to improve the efficacy and safety of the therapy, such as developing more sophisticated CARs and identifying new cancer-specific targets. Additionally, combination therapies that pair T Cell Transfer Therapy with other treatments like checkpoint inhibitors are being investigated to enhance overall outcomes.
